For example, triple-negative breast cancer (TNBC) – defined by the lack of estrogen and progesterone receptors as well as the absence of HER2 overexpression or amplification [3] – is associated with worse survival and higher frequencies of lung, brain, and distant nodal relapse compared to other breast cancer subtypes [2]. This evidence concerns the gene ERBB2 and breast carcinoma.